Union Korea Pharm Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Union Korea Pharm Co Ltd

Watchlist Manager

Watchlist

Price: 2 725 KRW -10.21% Market Closed

Market Cap: ₩21.6B

U	Union Korea Pharm Co Ltd KOSDAQ:080720	KR
	Molecular Partners AG F:6ML0	CH

Profitability Summary

Union Korea Pharm Co Ltd's profitability score is 9/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

10%

Sustainable 3Y Average Gross Margin

25%

Declining Gross Margin

36% > 10%

Negative Operating Margin

-60%

Negative 3Y Average Operating Margin

-37%

Declining Operating Margin

-2% > -60%

Negative Net Margin

-95%

Negative 3Y Average Net Margin

-57%

Declining Net Margin

-9% > -95%

Negative Free Cash Flow Margin

-6%

Negative 3Y Average Free Cash Flow Margin

-1%

Free Cash Flow Margin is Increasing

-7% > -6%

Negative ROE

-138%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-25%

Declining ROIC

-2% > -36%

View All

Hide

Collapse

9 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.